StockData

GPL Holdings, Inc. (GPLL) stock

GPLLOTCBlank ChecksFiscal year ends July 31
Số liệu tài chính tới Q1 năm tài chính 2024, quý kết thúc ngày Oct 31, 2023Last filing: 10-Q on Apr 26, 2024
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.56MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Oct 31, 2023

Valuation

Market cap
$2.56M
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Net income
-$55.58K
EPS, diluted
$0.00
Book value per share
-$0.00
Diluted shares
227M

Trading

Previous close
$0.01
Open
$0.01
Day's range
$0.01 – $0.01
Volume
0

Market cap history

Month-end market cap since 2023, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodGPLLS&P 500DifferenceGPLL per yearS&P 500 per year
1 month0.0%+0.6%−0.6 pts
3 months-38.9%+3.4%−42.3 pts
Year to date-66.2%+13.3%−79.4 pts
1 year-71.8%+16.6%−88.4 pts
3 years-71.8%+86.4%−158.1 pts-34.4%+23.1%

Three years at a glance

Fiscal years 2021 to 2023 and trailing twelve months, USD

Net income

-$55.58K

EPS, diluted

$0.00
Reported periodTrailing twelve months

Press releases

Releases GPL filed with the SEC as exhibits to Form 8-K or 6-K

About GPL

Blank Checks

GPL Holdings, Inc. is a biopharmaceutical company engaged in developing novel therapies and supplying affordable healthcare items, including prescription and over-the-counter pharmaceuticals, medical and dental equipment, and healthcare supplies. Operating through its subsidiary, Global Pharma Labs, Inc., the company focuses on advancing its preclinical osteoarthritis therapy, OA-sys, toward clinical trials. In addition, it develops medication therapies targeting conditions such as onychomycosis, erectile dysfunction, cold sores, shingles, and genital herpes. The enterprise aims to serve healthcare consumers and distribution channels requiring affordable treatment options.

Company profile, executives and history

GPL stock: common questions

What is GPL's stock price?

GPLL closed at $0.01 on Oct 19, 2026, up 0.00% on the day.

What is GPL's market cap?

GPL was worth $2.56M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is GPLL's P/E ratio?

GPL lost money over the twelve months to Oct 31, 2023 (diluted EPS $0.00), so it has no meaningful P/E ratio.

Does GPL pay a dividend?

No. GPL has not paid a cash dividend over the last twelve months.

How has GPLL stock performed over the past year?

Including dividends, GPLL returned -71.8% over the past year, against +16.6% for the S&P 500.

Who are GPL's competitors?

Companies most similar to GPL by business, industry and size include OACC, AFJK, LPAA, SORN, DMII.

See a number that looks wrong?